This site is intended for healthcare professionals only
King Pharmaceuticals, Auden Mckenzie, Lexon (UK) and Alissa Healthcare broke the law in relation to nortriptyline supply, according to the Competitions and Markets Authority (CMA).
An investigation into the supply of nortriptyline by four pharmaceutical companies found two breaches of competition law, resulting in fines of almost £3.4m, a payment of £1m to the NHS and the disqualification of a director of King Pharmaceuticals, the CMA announced yesterday (March 4).
Register to gain full access to C+D and C+D Community content
Already registered?
Already registered?
Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.
C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…
Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.
Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.
Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.
